RxDoctor Payments Data

Sharon Fekrat, MD

Ophthalmology · Wilson, NCNPI 1235191115

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $87,976 of the $113,178 with a category attached, or 77.7%. It is spread thinly across 26 manufacturers, the largest accounting for just 17.3%. 2025 is the largest year on record at $48,575, more than ten times the $693 reported in 2019. Among ophthalmology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$113,178in general payments, 2019–2025

Across 181 payments — averaging $625.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$20K
  • Bausch & Lomb Americas Inc.$18K
  • Apellis Pharmaceuticals, Inc.$16K
  • Alcon$15K
  • Regeneron$12K
  • Genentech USA, Inc.$12K
  • plus $20K from 20 others
$32,604in research payments, 2019–2025

Across 4 payments — averaging $8150.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Carl Zeiss Meditec, Inc.$26K
  • F. Hoffmann-la Roche AG$4K
  • Genentech, Inc.$3K

What the payments were for

  • Consulting fees$87,97678%
  • Travel & lodging$15,20713%
  • Food & beverage$9,9969%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$113,178 in reported general payments places this provider in the 95th percentile of 588 ophthalmology providers in North Carolina.

See all ophthalmology providers in North Carolina

Medicare billing

Part B allowed, 2024
$136,824
Medicare patients
268
Services billed
1,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate73$2,853
Ketorolac Tromethamine85$1,712
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat18$356
Latanoprost20$180
Brimonidine Tartrate14$82

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Wilson

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →